Fangchinoline is a novel anti-tumour agent with little known of its cellular and molecular mechanisms of action. Here we have investigated the mode of cell death induced by fangchinoline and its underlying mechanism in two human hepatocellular carcinoma cell lines, HepG2 and PLC/PRF/5.
Introduction
Autophagy is a mechanism of membrane-trafficking where cytoplasmic proteins and constituents are delivered to lysosomes for further degradation (Tang et al., 2006; Tian et al., 2006) . The molecular mechanism underlying the induction of autophagy in mammalian cells is not completely described but so far more than 30 genes have been identified to be related to autophagy in yeast (Bommareddy et al., 2009) . Autophagic vacuolization is observed in the pathogenesis of numerous neoplasms, as well as in cancer chemotherapy, indicating that the role of autophagy in cancer is far from simple. Many studies reveal that autophagy could act as a survival pathway or contribute to cell death in tumour cells treated with chemotherapeutic agents (Mizushima et al., 1998; Hanahan and Weinberg, 2000; Cheng et al., 2009) . In many cases, induction of basal autophagy, the self-eating process, facilitates the breakdown of some long-life cytoplasmic proteins and dysfunctional organelles to counteract the deleterious effect of endogenous metabolic stress, in response to chemotherapeutic agents and leads to tumour cell survival, while excessive autophagy induced by drugs leads to elimination of tumour cells and plays an antitumour role when autophagy comes to completion (Chen and Karantza-Wadsworth, 2009 ). The term 'autophagic cell death' (ACD) is extensively employed to indicate that cells are undergoing an alternative type of programmed cell death subroutine, lacking the morphological features of classical apoptosis and manifesting with the excessive accumulation of autophagosomes in the cytoplasm . In view of this complexity, the role of autophagy must be clarified case by case.
Fangchinoline is a bis-benzylisoquinoline alkaloid with of complex structure and has been identified as a new compound, sharing structural features with tetrandrine, another compound with a wide spectrum of anti-tumour activity in various cancer cells. The potent anti-tumour activity of tetrandrine has been extensively reported with its proposed mechanism of inducing G1/S and G2/M arrest and stimulating apoptotic cell death (Zhang et al., 2003; Meng et al., 2004; Sun et al., 2007) . However, the anti-tumour activity of fangchinoline and its underlying mechanism(s) remain unclear.
Here, we report the potent anti-tumour action of fangchinoline in two hepatocellular carcinoma cell lines, HepG2 and PLC/PRF/5. Fangchinoline induced hepatoma cell death at low concentrations (IC 50 was approximately 5 mM) in both HepG2 and PLC/PRF/5 cells, but fangchinoline used mechanisms different from those of its analogue, tetrandrine, to potentiate tumour cell death. Though incapable of inducing apoptosis or cell cycle arrest in tumour cells, fangchinoline was able to initiate ACD by increasing the nuclear translocation of p53 to transactivate the sestrin2 gene, a novel player in autophagy induction. Signalling by AMP-activated protein kinase (AMPK) was then activated as downstream target of sestrin2 and a mTOR-independent autophagy was induced. Inhibition of autophagy potentiated apoptosis when cells weare exposed to fangchinoline. To the best of our knowledge, this study provides the first evidence that fangchinoline may have potential as a chemotherapeutic agent, by inducing ACD in tumour cells.
Methods

Cell line and cell culture
The human hepatocellular carcinoma cell line HepG2 was purchased from American Type Culture Collection (USA); the human hepatoma cell line PLC/PRF/5 was provided by Professor Tsao Sai-Wah. Rat normal hepatic cell line buffalo rat liver (BRL) was purchased from Sun Yat-Sen University (China). Cells were maintained in high glucose Dulbecco's Modified Eagle Medium (Invitrogen, USA) supplemented with 10% fetal bovine serum (Invitrogen, USA), and incubated in a humidified atmosphere containing 5% CO2 at 37°C.
Cell viability assay
Cells were seeded in 96-well plate with density of 10 4 cells per well. A series of concentrations of fangchinoline or tetrandrine (0, 10 -3 , 10 -2 , 10 -1 , 1, 10, 10 2 , 10 3 mM) were added and followed by 24 h incubation. All experiments were conducted parallel with controls (0.1% DMSO). Cell viability was determined by MTT assay.
Clonogenic assay
Clonogenic assay was conducted as described (Franken et al., 2006) with some modifications. Briefly, HepG2 and PLC/ PRF/5 cells were seeded into six-well plates at a density of 10 3 cells per well. Twenty-four hours after seeding, cells were treated with various concentrations of fangchinoline for 12 days. Drugs were replaced when medium was refreshed. Plates were then washed with PBS, and cells were fixed in 4% paraformaldehyde and stained with 0.1% Coomassie blue (Bio-Rad) in 30% methanol and 10% acetic acid. Images were captured by a CCD camera.
Monodansylcadaverine & Acridine Orange staining
For monodansylcadaverine (MDC) staining, cells were incubated with 0.05 mM MDC in PBS at 37°C for 10 min (Munafó and Colombo, 2001 ) and visualized with fluorescent microscopy (Carl Zeiss, USA, 630 ¥ magnification, CCD camera). For Acridine Orange (AO) staining, cells with or without treatment were stained by 1 mg·mL -1 AO in PBS at 37°C for 15 min . Then cells were washed and visualized with a fluorescence microscope at 630 ¥ magnification (Carl Zeiss, Germany).
Quantification of GFP-LC3 puncta
HepG2 cells with stable expression of GFP-LC3 were seeded into 35 mm confocal dishes and treated. The accumulation of GFP-LC3 was examined by fluorescent microscopy at 630 ¥ magnification. Autophagy was quantified by counting the percentage of cells showing accumulation of GFP-LC3 in dots. A total of 100 cells per preparation in three independent experiments were calculated. Cells presenting several intense punctate aggregations of GFP-LC3 were classified as showing autophagy (Shen et al., 2007) .
by 6 h incubation were used as positive control. Medium was then discarded and cells were stained with Annexin V/ propidium iodide (PI) kit (Roche, USA) according to the manufacturer's instructions. The stained cells were washed with PBS once and the cell cycle was analysed by flow cytometry (FC500, Beckman Coulter, USA).
Cell cycle analysis
Cells were seeded in six-well tissue culture plates and received different treatments. Cells were collected by trypsinization and fixed in 70% ethanol at 4°C overnight. Then cells were collected and resuspended in staining buffer (50 mg·mL -1 PI in PBS supplemented with 0.1% Triton X-100) for 15 min in dark at room temperature. The stained cells were washed with PBS once and the cell cycle was analysed by flow cytometry (FC500, Beckman Coulter, USA).
DNA fragmentation assay
Cells were harvested in lysis reagent (1% NP-40 in 20 mM EDTA, 50 mM Tris-HCl, pH 7.5) for 1 min with thorough vortex mixing followed by centrifugation. In total, 10 mL of proteinase K (25 mg·mL -1 , Sigma, USA) was added to the supernatant and incubated at 37°C for 2 h, 65 mL of 10 M ammonium acetate and 500 mL ice-cold ethanol were added and thoroughly mixed. The samples were stored at -80°C for 1 h to precipitate the DNA. DNA was collected by centrifugation and washed with 200 mL 80% ice-cold ethanol and airdried for 10 min. The residues were reconstituted in 30 mL of TE buffer and the DNA fragments was separated by 2% agarose gel and visualized with a UV transilluminator (Bio-Rad, USA).
Subcellular fractionation
Cells were harvested in ice-cold hypotonic buffer (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.4% NP-40, 0.05 mM dithiothreitol; DTT) supplemented with protease inhibitor cocktail (Roche, USA) for 5 mins followed by 14 000¥ g centrifugation at 4°C. Supernatant was collected as cytoplasmic fraction, and the pellet was further incubated with nuclear extraction buffer (20 mM HEPES, 400 mM NaCl, 1 mM EDTA, 0.05 mM DTT) supplemented with protease inhibitor cocktail (Roche, USA) on ice for 30 min. The lysate was then centrifuged at 14 000¥ g for 10 min at 4°C to obtain supernatant as nuclear fraction. Immunoblotting was performed to detect the localization of p53 in cytoplasm and nuclear. Lamin B1 and b-actin were used as loading controls for nuclear and cytoplasmic compartments respectively (Wei et al., 2008) .
Immunoblotting
Cells were lysed with radio-immunoprecipitation assay buffer supplemented with proteinase inhibitor on ice for 30 min and then centrifuged at 14 000¥ g at 4°C for 25 min. The supernatant was transferred and protein concentration was determined by using BSA as standard. Equal amounts of protein were resolved by SDS-PAGE and transferred onto a polyvinylidene fluoride membrane (Biorad). Then the membrane was blocked with 5% BSA in buffer overnight at 4°C. The membrane was then incubated with primary antibodies at 4°C overnight followed by incubation with appropriate secondary antibodies. The immunoreactivities were detected using electrochemiluminescence advanced kit (GE Healthcare, UK) and visualized using a chemiluminesence imaging system (Bio-rad, USA).
Quantitative real-time PCR
Total RNA of cells was purified by using RNeasy Mini Kit (Qiagen, Germany) following the manufacturer's instruction. Reverse-transcription reaction was performed using QuantiTech Reverse Transcription Kit (QIAGEN, Germany) to prepare cDNA samples. The quantitative real-time PCR was conducted by QuantiTect SYBR Green PCR Kit (Qiagen, Germany) with 1 mM primers for DRAM (forward: 5′-TCAAATATCACCATTGATTTCTGT-3′; reverse: 5′-GCCA CATACGGATGGTCATCTCTG-3′; Invitrogen, USA) or 1 mM sestrin2 primers (forward: 5′-GCATTACCTGCTGCTGCATA-3′; reverse: 5′-AAGGCCTGGATATGCTCCTT-3′; Invitrogen, USA) on LightCycler 480 real-time PCR system (Roche, USA). The expression of GAPDH was used as endogenous control (forward: 5′-GCTAGGGACGGCCTGAAG-3′; reverse: 5′-GC CCAATACGACCAAATCC-3′; Invitrogen, USA). 4 ng of cDNA was used for each reaction.
RNA interference
Cells were transfected with siRNA against human Atg5 or AMPKa (20 nM, Santa Cruz Biotechnology Inc., USA) using transfection reagent Lipofectamine 2000 (Invitrogen, USA) in serum-and antibiotic-free medium for 6 h followed by 48 h incubation in normal medium.
Statistical analysis
Results were analysed using Student's t-test and are expressed as mean Ϯ SD.
Materials
Fangchinoline and tetrandrine were isolated from Radix of Stephaniae tetrandrae (Han-Fang-Ji in Chinese) by Professor Liang Guanyi. The purity of each chemical was more than 99.0%. Propidium iodide (PI, P4170), bafilomycin A1 (B1793), leupeptin (L9783), pifithrin-a (P4236) and compound C (P5499) and Ac-DEVD-CHO (A0385) were purchased from Sigma-Aldrich (USA). The pEGFP-C1 plasmid encoding human LC3 was a kind gift from Professor Tamotsu Yoshimori, Osaka University.
Results
Fangchinoline induced death of hepatoma cell lines, HepG2 and PLC/PRF/5 in vitro
In our study, a dose-dependent reduction in tumour cell viability after fangchinoline treatment for 24h was observed. The IC50 of fangchinoline was approximately 5 mM in both HepG2 and PLC/PRF/5 cells ( Figure 1A) . Tetrandrine, the derivative of fangchinoline, also exhibits potent cytotoxicity to HepG2 and PLC/PRF/5 cells ( Figure 1A ). Sustained treatment, over 12 days, with fangchinoline resulted in cell death at a lower concentration than its IC50 deterrnined after 24 h ( Figure 1B) ; 2 mM of fangchinoline in HepG2 cells and 4 mM in PLC/PRF/5 cells were enough to potently inhibit tumour cell growth. No drug-resistance was observed during the sustained treatment of fangchinoline.
Fangchinoline did not induce apoptotic cell death in hepatoma cells
Here we used Annexin V/PI double staining to identify the involvement of apoptosis in fangchinoline-induced cell death. No increase in apoptosis was observed between cells exposed to vehicle and various doses of fangchinoline, while cells exposed to UV showed clear apoptotic changes ( Figure 2A ). Cells treated with 10 mM tetrandrine also exhibited apoptotic features. Cell cycle analysis showed that tetrandrine, but not fangchinoline, markedly induced G0/G1 cycle arrest in both the hepatoma cell lines ( Figure 2B ). Consistent with these findings, cells exposed to UV and tetrandrine exhibited nuclear fragmentation but no DNA fragments could be found in hepatoma cells after treatment with fangchinoline ( Figure 2C ). Immunoblotting analysis revealed that fangchinoline treatment did not increase the cleavage of poly-ADP ribose polymerase (PARP), a protein marker of apoptosis ( Figure 2D ). These results were further confirmed by the observation that fangchinoline-induced cell death could not be attenuated in the presence of 50 mM of Ac-DEVD-CHO, a caspase inhibitor ( Figure 2E ).
Fangchinoline induces autophagy in hepatoma cells HepG2 and PLC/PRF/5
In our study, dose-dependent increases of MDC and AO staining in hepatoma cells exposed to fangchinoline showed the accumulation of autophagic vacuoles in acidic compartments enriched in lipids (Bampton et al., 2005) , which may indicate an autophagy induction by fangchinoline ( Figure 3A,B) . Induction of autophagy by fangchinoline was confirmed by the immunoblot analysis on expression of LC3-II, a biomarker of autophagy ( Figure 3C ). In contrast, tetrandrine was not able to induce autophagy at 10 mM, at which dose it exhibits potent pro-apoptotic action ( Figure 3A-C) . To further describe the role of autophagy in the anti-tumour action of fangchinoline, we examined if fangchinoline could also induce autophagy in normal hepatic cells. No induction of autophagy was observed in BRL cells with 5 or 10 mM fangchinoline treatment, concentrations which were capable of killing tumour cells ( Figure 3C ). Moreover, to further elucidate that exposure to fangchinoline could induce autophagy, HepG2 cells stably expressing GFP-LC3 were treated with fangchinoline for 24 h and significant increase of green fluorescent signal was observed, indicating accumulation of GFP-LC3 protein in cells exposed to fangchinoline. This accumulation of GFP-LC3 was blocked by siRNA for the Atg5 gene ( Figure 3D ).Similar results were observed in the quantification of GFP-LC3 cell localisation, showing that fangchinoline intervention increases the punctate nature of the autophagosomes and that this inductive action was blocked by Atg5 gene silencing ( Figure 3D ). To monitor the dynamics of fangchinoline-induced autophagy, we exposed HepG2 cells to different doses of fangchinoline in the presence of bafilomycin A1 (32 nM) or leupeptin (50 mM). Addition of bafilomycin A1 blocked the fusion process of autophagosome and lysosome, and we observed a significant decrease of LC3-I, the 18 kDa cytosolic constituent, after fangchinoline treatment while the lipid membrane form of LC3-II remained the same ( Figure 3E ). However, the presence of the lysosome inhibitor leupeptin, which blocks the lysosomal degradation of autophagic vacuoles, revealed no effect on fangchinolineinduced autophagy in HepG2 cells ( Figure 3E ). Different patterns of fangchinoline-induced autophagy in cells in the presence of bafilomycin A1 or leupeptin indicates that fangchinoline initiates autophagy by slowing the off-rate process (lysosomal degradation) of autophagy rather than increasing the on-rate process (autophagosome formation).
Fangchinoline induces translocation of p53 in hepatoma cells
The human tumour suppressor protein p53, which transactivates many of pro-apoptotic and cell cycle arresting-related genes, is well recognized for its ability to induce apoptosis. As a transcriptional factor, a novel function of p53 in regulating autophagy has been identified by recent studies. The pool of cytoplasmic p53 may repress autophagy ina transcriptiondependent manner whereas translocation of p53 into the nucleus induces autophagy via activating the transcription of specific genes ). In our study, no significant decrease of the total level of p53 protein in cells treated with fangchinoline could be observed. However, a concentrationdependent increase of nuclear import of p53 could be found in both HepG2 and PLC/PRF/5 cells exposed to fangchinoline ( Figure 4A ), indicating that fangchinoline may act as a modulator to increase the p53 nuclear localization without altering its total expression level. The autophagy-inducing action of fangchinoline was completely blocked by co-treatment with pifithrin-a (20 mM), suggesting a central role of p53 in fangchinoline-stimulated autophagy in hepatoma cells ( Figure 4B ). Although the exact mechanism of pifithrin-a in inhibiting p53 transcription activity remains unclear, initial study suggested that pifithrin-a may modulate the nuclear import or export of p53, or may decrease the stability of nuclear p53 (Waters et al., 2010) . Our results suggest that the transcriptional activity of p53 is required for the initiation of autophagy in hepatoma cell exposed to fangchinoline.
Involvement of senstrin2 but not DRAM in fangchinoline-induced autophagy in hepatoma cells
We examined the conventional signal transduction pathways which may activate autophagy in human cancer cells. As we observed, fangchinoline has little effect on Beclin-1, p38 MAPK, p42/p44 MAPK or Akt signalling pathway ( Figure 4C ). Autophagy induction by p53 nuclear translocations included the up-regulation of DRAM and sestrin2 in p53-sufficient but not in p53-deficient cells . Determined by quantitative real-time PCR, increased sestrin2 transcript but not that of DRAM could be observed in cells treated with fangchinoline. Consistent with this, adding the p53 inhibitor, pifithrin-a, completely blocked the transactivation of sestrin2, suggesting that nuclear import of p53 may be required for the transcriptional activation of sestrin2 ( Figure 5A ). Recent studies found that removal of sestrin2 could suppress autophagy induced by various stimulators, where activation of AMPK signalling and inhibition of mTOR are involved as the key mechanisms (Budanov and Karin, 2008; D'Amelio and Cecconi, 2009 ). To further examine the effect of p53 translocation on the AMPK/mTOR signalling pathway, cells were exposed to fangchinoline in the presence or absence of pifithrin-a. We observed that the AMPK signalling could be activated by treatment of fangchinoline in the absence of pifithrin-a. However, this stimulatory effect of fangchinoline on AMPK pathway as well, was completely down-regulated ( Figure 5B ). The induction of autophagy was attenuated in the presence of an AMPK inhibitor or siRNA to AMPKa ( Figure 5C,D) . These results indicate that AMPK activation may be necessary for fangchinoline-induced autophagy. It has been reported that mTOR inhibition follows as a downstream target of AMPK activation. Controversially, we found that fangchinoline could induce autophagy via the activation of the AMPK pathway without inhibiting either phosphorylation of mTOR or of its substrates p70 S6 kinase and S6 ribosomal protein ( Figure 5E ). This reveals that a bypassing mechanism of AMPK signalling targets to autophagy activation independent of mTOR suppression, may be involved in fangchinoline's action. 
Inhibition of autophagy switches it to apoptosis in hepatoma cells with fangchinoline intervention
Because autophagy is a novel property of fangchinoline in inducing tumour cell death, we further examined that whether inhibition of autophagy in fangchinoline-treated cells resulted in cell survival. Interestingly, by inhibiting autophagy through genetic inhibition of Atg5, we found that apoptosis was initiated in HepG2 cells exposed to fangchinoline ( Figure 6A ). This observation was further confirmed by immunoblotting, where cleavage of PARP, a marker of cell undergoing apoptosis (Oliver et al., 1998) , was significantly increased when autophagy was inhibited in HepG2 cells exposed to fangchinoline ( Figure 6B ). Our results indicated that apoptosis may be an alternative route to cell death induced by fangchinoline when ACD is inhibited.
Discussion
Fangchinoline was reported to exert several pharmacological actions in vitro and in vivo, including anti-inflammatory (Hris- 
Figure 4
Fangchinoline induced translocation of p53 in HepG2 and PLC/PRF/5 cells. (A) Cells exposed to various doses of fangchinoline was harvested and cytosolic protein and nuclear protein were isolated using different extraction buffer and analysed by immunoblotting. *P < 0.05, **P < 0.01 significantly different from control. (B) HepG2 cells stably expressing GFP-LC3 fusion protein were exposed to fangchinoline for 24 h in the presence or absence of pifithrin-a (20 mM) and then visualized (630 ¥ magnification). Percentage of cells with autophagic punctate fluorescence was determined. P < 0.01 significantly different from control. ##P < 0.01 significantly different between the presence and absence of pifithrin-a (20 mM). All above results are representative of three independent experiments and are shown as mean + SD. (C) HepG2 and PLC cells was treated with fangchinoline for 24 h and the total protein was collected. Protein expression was determined by immunoblotting.
tova and Istatkova, 1999), anti-malarial (Lin et al., 1993) , anti-oxidative (Gülçin et al., 2010) , anti-hypertensive (Kim et al., 1997) and neuro-protective (Lin et al., 2009) effects. Fangchinoline was also reported to be able to help chemotherapeutic agents overcome multidrug resistance in cancer cells (Wang et al., 2005) . A recent study showed that fangchinoline exhibits potent anti-tumour activity in human prostate carcinoma both in vitro and in vivo by inhibiting G1/S phase transition in PC3 cells (Wang et al., 2010) . However, unlike its derivative tetrandrine whose anti-tumour action and proposed mechanism has been extensively studied in various types of cancer cells, fangchinoline is still under investigation of its potential in application as an anti-tumour agent. Here we report fangchinoline's action on hepatocellular carcinoma cell lines HepG2 and PLC/PRF/5. We found that fangchinoline significantly induced cell death and decreased tumour cell survival in a concentration-dependent manner. Interestingly, although it has a very similar chemical structure to tetrandrine, which induces apoptosis in different tumour cells including hepatocellular carcinoma cells (Yoo et al., 2002) , fangchinoline exerts an entirely different cell death mechanism, where autophagic cell death (ACD) was the dominant machinery of programmed cell death.
Cell death is a complicated process in which several mechanisms may be involved. Apoptosis, known as the type I programmed cell death, was identified as the major component in the death of mammalian cells under physiological conditions (Kerr, 1965) and is a rapid and irreversible process under the control of several cell intrinsic and extrinsic pathways (Adam, 2003; Danial and Korsmeryer, 2004; Gelinas and White, 2005) . ACD was identified in the 1990s with the discovery of autophagy-related (Atg) genes (Kroemer and Levine, 2008) . As a complementary mechanism of cell death, ACD is distinguished from apoptosis by non-apoptotic morphology and independence from caspases (Maiuri et al., 2007) . Our study shows that compounds with very similar chemical structure may have quite distinct mechanisms though both of them have an overall antitumour effect.
Several signal pathways have been reported to be involved in the induction of autophagy, including Beclin-1(Atg6), PI3K/Akt/mTOR, calcium signalling, endoplasmic reticulumstress and Ras/Raf/MAPK pathway (Chen and KarantzaWadsworth, 2009 ). Recently, a new contributor to the induction of autophagy has been identified, the tumour suppressor protein, p53. A series of recent studies showed a dual 
Figure 5
Signal transduction involved in fangchinoline-induced autophagy. (A) Cells were treated with fangchinoline for 24 h in the presence or absence of pifithrin-a (20 mM).Transcript Expression of transcripts for DRAM and sestrin2 were detected by quantitative PCR. *P < 0.05, **P < 0.01 when compared with control. (B) Cells were exposed to fangchinoline for 24 h in the presence or absence of pifithrin-a (20 mM). Protein expression was analysed by immunoblotting. (C) Cells were exposed to fangchinoline for 24 h in the presence or absence of compound C (20 mM). Protein was analysed by immunoblotting. (D) Cells were exposed to fangchinoline for 24 h in the presence or absence of siRNA to AMPKa (20 nM). Protein was analysed by immunoblotting. (E) Cells were treated with fangchinoline for 12 or 24 h. Protein was analysed by immunoblotting. All above results are representative of three independent experiments. role for p53 in autophagy regulation. On accumulation in the cytosol, p53 serves as an inhibitor of autophagy and in human, mouse and nematode cells subjected to knockout, knockdown or pharmacological inhibition of p53 enhances autophagy by inducing LC3 redistribution both in vitro and in vivo . Translocation of p53 into the nucleus induces the transactivation of the autophagy-related genes, DAPK-1 (Harrison et al., 2008) , DRAM (Crighton et al., 2006) and sestrin2 , and triggers their expression which eventually induces the autophagy process. Blockade of the nuclear export signal which recruits p53 to the nucleus completely reverses the autophagy-inhibitory effect of cytosolic p53 (Morselli et al., 2008) . In our study, we found that fangchinoline specifically recruited p53 to the nucleus and selectively triggered the expression of sestrin2 but not of DRAM, which then stimulated AMPK signal transduction in HepG2 and PLC/PRF/5 cells. Addition of the p53 inhibitor, pifithrin-a, blocked the induction of sestrin2 by fangchinoline and down-regulated AMPK signalling as well as fangchinoline-triggered autophagy. Activation of AMPK signalling inhibits the negative regulator of autophagy mTOR and thus stimulates autophagy (Viana et al., 2008) . In our study, we observed that induction of autophagy by fangchinoline was down-regulated by the AMPK inhibitor, compound C, or by the siRNA to AMPKa, indicating that AMPK activation is required for fangchinoline-induced autophagy in hepatoma cells. Surprisingly, we found fangchinoline induced autophagy via AMPK signalling but independently of mTOR inhibition. This suggests that induction of autophagy through AMPK activation may work without signalling through mTOR. A recent study shows that presence of AICAR or other AMPK activators could activate AMPK signalling and affect protein degradation in an mTOR-independent manner (Poels et al., 2009) . Our assessment of the dynamics of autophagy induced by fangchinoline shows that fangchinoline acts on the off-rate dynamics by slowing down lysosome degradation. A possible mechanism of the induction of autophagy in our experiments is that activation of AMPK signalling by fangchinoline inhibits the proteosomal functions which then slows down the off-rate of autophagy. A growing number of investigations report an important role of AMPK signalling in autophagy induction (Boya et al., 2005) . These together with our finding indicate that AMPK may serve a major role in the stimulation of autophagy.
It is interesting to observe in our study that inhibition of fangchinoline-induced autophagy triggered a switch from autophagy to apoptosis. Some previous studies have revealed that there may be some molecular connections between apoptosis and autophagy, facilitating the switch between the two types of programmed cell death. Inhibition of the early stage of autophagy by the chemical inhibitor 3-methylamphetamine or genetic deletion of Atg5, Atg6/Beclin-1, Atg10 and Atg12 sensitizes cells to death with a common feature of apoptosis when cells are starved (Jin et al., 2007) . As a well-documented condition that may induce autophagy, starvation-induced cell death switches to apoptosis when autophagy is suppressed, indicating that the two types of programmed cell death may be complementary to each other. The exact mechanisms involved in fangchinoline-induced apoptosis when ACD is inhibited is under investigation.
In conclusion, the mode of cell death induced by fangchinoline in HepG2 and PLC/PRF/5 hepatocellular carcinoma cells has been investigated. We found that fangchinoline did not induce apoptosis in HepG2 and PLC/PRF/5 cells. Instead, an excessive autophagy was triggered by fangchinoline, concentration-dependently, initiating an alternative mode of cell death which may contribute to fangchinoline's antitumour action. Nuclear localization of p53 in tumour cells exposed to fangchinoline selectively transactivated the autophagy-related sestrin2 and stimulated AMPK signalling to initiate the autophagic process. Blockade of AMPK signalling attenuated autophagy induction in fangchinoline-treated cells. Genetic inhibition of Atg5 blocked induction of autophagy fangchinoline and switched it to apoptosis, in hepatocellular carcinoma cells. Our results shed light on the potential of fangchinoline as a tumour therapy agent with a novel mechanism in mediating cancer cell death.
